Self-Control and Adverse “Drinking” Consequences

Most research on adverse alcohol consequences such as problems with health, work, and relationships focuses only on alcohol use itself as a cause of these outcomes. However, Gottfredson and Hirschi’s (1990) self-control theory holds that alcohol use and these negative outcomes are likely to have a common cause–low self-control. Tests of hypotheses derived from self-control theory show that self-control predicts negative drinking consequences better than combined measures of alcohol dependence and frequency and quantity of drinking. This suggests that various forms of risk–taking behavior and negative outcomes can be conceptualized as indicators of underlying levels of self-control

Synergetic improvement in electromagnetic interference shielding characteristics of polyaniline-coated graphite oxide/γ-Fe2O3/BaTiO3 nanocomposites

Polymer nanocomposites were prepared by in situ polymerization of aniline with graphite oxide (GO), γ-Fe2O3, and BaTiO3 as electromagnetic interference (EMI) shielding materials. GO, γ-Fe2O3, and BaTiO3 nanoparticles were incorporated in the nanocomposites to improve the electromagnetic properties. The nanocomposites showed the significant improvement in both EMI shielding efficiency (SE) and thermal property due to the thermal conductivity of GO, the magnetic effect of γ-Fe2O3, and the electric effect of BaTiO3. The EMI SE of nanocomposites was improved due to the synergetic effect of reflection and absorption of electromagnetic interference by GO, γ-Fe2O3, and BaTiO3 additives

Determining the chronology and components of psychosis onset : the Nottingham Onset Schedule (NOS)

The Nottingham Onset Schedule (NOS) is a short, guided interview and rating schedule to measure onset in psychosis. Onset is defined as the time between the first reported/observed change in mental state/behaviour to the development of psychotic symptoms. Onset is conceptualised as comprising of (i) a prodrome of two parts: a period of ‘unease’ followed by ‘non-diagnostic’ symptoms; (ii) appearance of psychotic symptoms; and (iii) a build-up of diagnostic symptoms leading to a definite diagnosis. Twenty consecutive cases of first-episode psychosis were administered the NOS schedule to determine its psychometric properties including inter-rater and test–retest reliability. Its clinical and research potential as a reliable measure of duration of untreated psychosis (DUP) was assessed in a cohort of 99 cases of first-episode psychosis (56 schizophrenia, 43 affective psychoses). NOS identified all prodromal symptoms previously reported in other studies. There was high degree of inter-rater and test–retest reliability for all components of NOS. Duration of untreated psychosis was significantly longer (p<0.05) in schizophrenia (mean 179 days, S.D. 344; median 52 days) than in affective psychosis (mean 15 days, S.D. 116; median 12 days) but there were no gender differences between lengths of prodrome or treatment delays. The NOS provides a standardised and reliable way of recording early changes in psychosis and identifying relatively precise time points for measuring several durations in emerging psychosis. The scale is easy to use and is not time-consuming or labour intensive. Onset, as measured by NOS, is significantly longer in schizophrenic disorders than in affective psychosis. A small proportion of schizophrenia cases have very long DUP. Some cases with schizophrenia receive anti-psychotics in the prodromal phase, prior to the emergence of frank psychotic symptoms